These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 25156780)

  • 21. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Terakura D; Shimizu M; Iwasa J; Baba A; Kochi T; Ohno T; Kubota M; Shirakami Y; Shiraki M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Carcinogenesis; 2012 Dec; 33(12):2499-506. PubMed ID: 23027617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
    Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
    Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.
    Iwasa J; Shimizu M; Shiraki M; Shirakami Y; Sakai H; Terakura Y; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Sci; 2010 Feb; 101(2):460-7. PubMed ID: 19906067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease.
    Kawamura-Yasui N; Kaito M; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    J Clin Lab Anal; 1999; 13(1):31-4. PubMed ID: 10025735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
    Miura K; Taura K; Kodama Y; Schnabl B; Brenner DA
    Hepatology; 2008 Nov; 48(5):1420-9. PubMed ID: 18671304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
    Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
    EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
    Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
    Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis.
    Hino K; Nishina S; Hara Y
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():93-8. PubMed ID: 24251712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis.
    Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE
    Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus.
    Liu H; Trinh TL; Dong H; Keith R; Nelson D; Liu C
    PLoS One; 2012; 7(10):e46631. PubMed ID: 23110054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
    Ohta K; Ito M; Chida T; Nakashima K; Sakai S; Kanegae Y; Kawasaki H; Aoshima T; Takabayashi S; Takahashi H; Kawata K; Shoji I; Sawasaki T; Suda T; Suzuki T
    PLoS Pathog; 2023 Aug; 19(8):e1011591. PubMed ID: 37585449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease.
    Kuwahata M; Kubota H; Kanouchi H; Ito S; Ogawa A; Kobayashi Y; Kido Y
    Nutr Res; 2012 Jul; 32(7):522-9. PubMed ID: 22901560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of maternal branched-chain amino acid and alanine supplementation on growth and biomarkers of protein metabolism in dams fed a low-protein diet and their offspring.
    Choi W; Kim J; Ko JW; Choi A; Kwon YH
    Amino Acids; 2022 Jul; 54(7):977-988. PubMed ID: 35353249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
    Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
    J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.